Literature DB >> 20614393

Disseminated intravascular coagulation in term and preterm neonates.

Alex Veldman1, Doris Fischer, Marcel F Nold, Flora Y Wong.   

Abstract

Among critically ill patients, the risk of developing disseminated intravascular coagulation (DIC) is probably highest in neonates. Low plasma reserves in pro- and anticoagulant coagulation factors, intravascular volume contraction after birth, and a high incidence of hypoxia and sepsis in critically ill newborns rapidly lead to a decompensation of the coagulation system in this population. Global coagulation tests and single-factor plasma levels have to be interpreted in the context of age-corrected normal ranges. Platelet consumption and reduced protein C plasma levels have diagnostic value; the latter also has prognostic potential in neonates with DIC and sepsis. Therapeutic success relies heavily on reversal of the underlying condition. Some coagulation-specific therapies have been explored in small studies and case series with varying success and sometimes conflicting results. Therefore, larger controlled trials in this common and serious condition are urgently needed. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20614393     DOI: 10.1055/s-0030-1254050

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  6 in total

1.  The effect of inhaled nitric oxide therapy on thromboelastogram in newborns with persistent pulmonary hypertension.

Authors:  Sema Tanriverdi; Ozge Altun Koroglu; Ozgun Uygur; Can Balkan; Mehmet Yalaz; Nilgun Kultursay
Journal:  Eur J Pediatr       Date:  2014-05-04       Impact factor: 3.183

2.  Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.

Authors:  Akira Shirahata; Jun Mimuro; Hoyu Takahashi; Isao Kitajima; Hajime Tsuji; Yutaka Eguchi; Tadashi Matsushita; Masahiro Kajiki; Goichi Honda; Yoichi Sakata
Journal:  Eur J Pediatr       Date:  2013-09-05       Impact factor: 3.183

3.  Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial cells.

Authors:  Jeffrey S Buzby; Shirley A Williams; Karen L Imfeld; Thomas J Kunicki; Diane J Nugent
Journal:  Inflamm Res       Date:  2014-01-03       Impact factor: 4.575

Review 4.  Disseminated Intravascular Coagulation in Varying Age Groups Based on Clinical Conditions.

Authors:  Elizabeth Geyer-Roberts; Tanisha Akhand; Alexandra Blanco; Robin Jose; Nayeem Chowdhury; Michael Ea; Eric Gutierrez; Jacqueline Balbuena; Sophia Anagnostis; Claudia Henderson; Alexis Fazio; Alexander Burpee; Robin J Jacobs
Journal:  Cureus       Date:  2022-04-21

5.  Risk factors and treatments for disseminated intravascular coagulation in neonates.

Authors:  Hayato Go; Hitoshi Ohto; Kenneth E Nollet; Nozomi Kashiwabara; Kei Ogasawara; Mina Chishiki; Shun Hiruta; Ichiri Sakuma; Yukihiko Kawasaki; Mitsuaki Hosoya
Journal:  Ital J Pediatr       Date:  2020-04-29       Impact factor: 2.638

6.  Disseminated intravascular coagulation and its immune mechanisms.

Authors:  Narcis I Popescu; Cristina Lupu; Florea Lupu
Journal:  Blood       Date:  2022-03-31       Impact factor: 25.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.